Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Current Taxes (2018 - 2025)

China SXT Pharmaceuticals has reported Current Taxes over the past 8 years, most recently at -$13199.0 for Q3 2025.

  • For Q3 2025, Current Taxes fell 101.21% year-over-year to -$13199.0; the TTM value through Sep 2025 reached -$13199.0, down 101.21%, while the annual FY2025 figure was $1.0 million, 2.0% down from the prior year.
  • Current Taxes for Q3 2025 was -$13199.0 at China SXT Pharmaceuticals, down from $1.0 million in the prior quarter.
  • Over five years, Current Taxes peaked at $1.2 million in Q1 2022 and troughed at -$13199.0 in Q3 2025.
  • A 5-year average of $663432.8 and a median of $1.0 million in 2024 define the central range for Current Taxes.
  • Biggest five-year swings in Current Taxes: plummeted 105.06% in 2023 and later surged 66041.87% in 2024.
  • Year by year, Current Taxes stood at $4163.0 in 2021, then surged by 688.33% to $32818.0 in 2022, then plummeted by 105.06% to -$1660.0 in 2023, then surged by 66041.87% to $1.1 million in 2024, then crashed by 101.21% to -$13199.0 in 2025.
  • Business Quant data shows Current Taxes for SXTC at -$13199.0 in Q3 2025, $1.0 million in Q1 2025, and $1.1 million in Q3 2024.